Embryonic Stem-Cell Patent Infringes EU Law, Top Court Says

Patent protection for stem-cell research methods that involve cells from human embryos breaches European Union law, the region’s highest court said.

To contact the reporter on this story: Stephanie Bodoni in Luxembourg at sbodoni@bloomberg.net

To contact the editor responsible for this story: Peter Chapman at pchapman10@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.